Oculis Holding AG (OCS) EBIT (2022 - 2026)

Oculis Holding AG's EBIT history runs 5 years deep, the most recent figure standing at -$27.7 million for Q1 2026.

• On a quarterly basis, EBIT fell 24.89% year-over-year to -$27.7 million in Q1 2026; TTM through Mar 2026 was -$78.7 million, a 17.77% decrease from a year earlier, with the FY2025 full-year figure at -$98.5 million, down 18.38% from the prior year.
• EBIT fell to -$27.7 million in Q1 2026 per OCS's latest filing, from -$25.8 million in the prior quarter.
• Across five years, EBIT topped out at -$20926.9 in Q3 2024 and bottomed at -$48.5 million in Q1 2023.
• The 5-year median for EBIT is -$16.1 million (2024), against an average of -$17.5 million.
• Biggest YoY gain for EBIT was 99.86% in 2024; the steepest drop was 108.06% in 2024.
• Year by year, EBIT stood at -$11.5 million in 2022, then decreased by 19.07% to -$13.7 million in 2023, then slumped by 43.44% to -$19.7 million in 2024, then plunged by 31.02% to -$25.8 million in 2025, then dropped by 7.48% to -$27.7 million in 2026.
• Per Business Quant, the three latest OCS EBIT figures stand at -$27.7 million (Q1 2026), -$25.8 million (Q4 2025), and -$25372.2 (Q3 2025).